RESUMO
Facial wrinkles are the predominant phenotypes of skin aging. To date, one of the most effective ways to improve wrinkles is botulinum toxin type A (BoNT/A) injection, which inhibits muscle contractions by reducing acetylcholine release from neurons. However, since BoNT/A is a hazardous neurotoxin, the injection can only be performed by medical doctors and the procedure is only possible through invasive injection, causing inconveniences such as pain. To overcome these inconveniences, we tried to find a way to reduce wrinkles non-invasively via mechanisms similar to BoNT/A. We first designed in vitro assays to test BoNT/A-like muscle contraction inhibition in two different model systems. By using the assays, we identified Zanthoxylum piperitum (Z. piperitum) fruit extract as a BoNT-like reagent (27.7% decrease of muscle contraction rates by 1000 ppm of Z. piperitum extract treatment). Next, we determined mechanisms of how Z. piperitum extract decreases muscle contraction rates and found that the extract treatment inhibits electrical signal transduction in neurons. We also showed that among known components of Z. piperitum extract, quercitrin is responsible for muscle contraction inhibition. We further identified that Z. piperitum extract has synergistic effects with acetyl hexapeptide-8 and BoNT/A light chain, which are well-known BoNT-like peptides. Finally, we showed that topical treatment of the Z. piperitum extract indeed decreases facial wrinkles and treatment of Z. piperitum extract with acetyl hexapeptide-8 has a tendency to improve wrinkles synergistically (14.5% improvement on average). The synergistic effect of the combination is expected to improve wrinkles effectively by implementing the BoNT/A mechanisms in a non-invasive way.
Assuntos
Extratos Vegetais/farmacologia , Envelhecimento da Pele/efeitos dos fármacos , Zanthoxylum/metabolismo , Acetilcolina/farmacologia , Adulto , Animais , Toxinas Botulínicas Tipo A/administração & dosagem , Caenorhabditis elegans , Linhagem Celular , Técnicas de Cocultura/métodos , Método Duplo-Cego , Pálpebras/efeitos dos fármacos , Feminino , Voluntários Saudáveis , Humanos , Camundongos , Pessoa de Meia-Idade , Contração Muscular/efeitos dos fármacos , Distribuição Aleatória , Ratos , República da CoreiaRESUMO
Cannabis is the most consumed illicit drug worldwide. As more countries consider bills that would legalize adult use of cannabis, health care providers, including eye care professionals (ophthalmologists, optometrists), will need to recognize ocular effects of cannabis consumption in patients. There are only 20 studies on the eyelid effects of cannabis usage as a medical treatment or a recreational drug. These include ptosis induction, an "eyelid tremor" appearance and blepharospasm attenuation. Six articles describe how adequately dosed cannabis regimens could be promising medical treatments for blepharospasm induced by psychogenic factors. Fourteen articles report eyelid tremors in intoxicated drivers and ptosis as a secondary effect in cannabinoid animal experimental models. The exact mechanism of cannabinoids connecting cannabis to the eyelids is unclear. Further studies should be conducted to better understand the cannabinoid system in relation to the eyelid and eventually develop new, effective and safe therapeutic targets derived from cannabis.
Assuntos
Blefaroptose/induzido quimicamente , Blefarospasmo/tratamento farmacológico , Canabinoides/uso terapêutico , Cannabis/efeitos adversos , Pálpebras/efeitos dos fármacos , Animais , HumanosAssuntos
Anti-Infecciosos Locais/uso terapêutico , Blefarite/tratamento farmacológico , Infecções Oculares Parasitárias/tratamento farmacológico , Pálpebras/efeitos dos fármacos , Higiene/normas , Infestações por Ácaros/tratamento farmacológico , Óleo de Melaleuca/uso terapêutico , Blefarite/parasitologia , Infecções Oculares Parasitárias/parasitologia , Promoção da Saúde , Humanos , Infestações por Ácaros/parasitologiaRESUMO
PURPOSE: To compare the single application and two week treatment effects of device-applied (Eyepeace) and manually-applied eyelid massage techniques, as an adjunct to warm compress therapy, on ocular surface and tear film parameters. METHODS: Twenty participants (11 females, 9 males; mean age, 27⯱â¯11 years) with dry eye symptoms were recruited in a two week, investigator-masked, randomised, contralateral-eye trial. Following 10â¯min of warm compress therapy application (MGDRx EyeBag®) on both eyes, eyelid massage therapy was applied to one eye (randomised) by device, and to the fellow eye by manual eyelid massage, once daily for 14 days. Ocular surface and tear film measurements were conducted at baseline, and 15â¯min post-application by a clinician, then again after 14 days of self-administered daily treatment at home. RESULTS: Baseline clinical measurements did not differ between the treatment groups (all pâ¯>â¯0.05). Following two weeks of treatment, tear film lipid layer grade improved significantly with device massage (pâ¯=â¯0.008), and was marginally greater than manual massage by less than 1 grade (pâ¯=â¯0.03). Although immediate post-treatment improvements in tear film stability were observed in both groups (both pâ¯<â¯0.05), no significant long-term cumulative effects or inter-treatment differences in stability measures were detected (all pâ¯>â¯0.05). Visual acuity, tear meniscus height, conjunctival hyperaemia, ocular surface staining, and meibomian gland dropout did not change during the treatment period (all pâ¯>â¯0.05). CONCLUSIONS: Two weeks of treatment with the eyelid massage device, as an adjunct to warm compress therapy, effected marginally greater improvements in tear film lipid layer thickness than the conventional manual technique, which were statistically but not clinically significant. Future parallel group trials with longer treatment periods and a greater range of disease severity are required.
Assuntos
Síndromes do Olho Seco/terapia , Pálpebras/fisiologia , Massagem/instrumentação , Disfunção da Glândula Tarsal/terapia , Adulto , Corantes/administração & dosagem , Método Duplo-Cego , Síndromes do Olho Seco/fisiopatologia , Pálpebras/efeitos dos fármacos , Feminino , Fluoresceína/administração & dosagem , Corantes Fluorescentes/administração & dosagem , Humanos , Corantes Verde de Lissamina/administração & dosagem , Masculino , Disfunção da Glândula Tarsal/fisiopatologia , Estudos Prospectivos , Inquéritos e Questionários , Lágrimas/fisiologia , Adulto JovemRESUMO
Information on background changes in the ocular tissues of rabbits ( Oryctolagus cuniculus), a common species employed in ophthalmic toxicology studies, is sparse. This complicates interpretation of changes in light of small sample sizes on any single study. The purpose of this publication is to document the interstudy incidence of spontaneous or iatrogenic changes occurring in eyes of control rabbits. Photomicrographs of select lesions are provided. The data set was derived from a total of 54 studies conducted over an eleven-year period at Alcon Research Ltd., a Novartis Division, which featured topical ocular and contact lens routes of administration. It includes a total of 1,222 pigmented and albino New Zealand rabbits and a total of 2,084 eyes which were either untreated or treated with innocuous control articles. There were no noteworthy differences across routes of administration. Changes in anterior segment ocular and adnexal tissues were more common than in posterior segment ocular tissues. Overall, mononuclear cell infiltration was the most common finding. The retina was the posterior tissue most commonly observed with spontaneous changes, with folds and rosettes being the most common retinal finding. Retinal changes were more common in albino as compared to pigmented rabbits. Understanding the incidence and characteristics of spontaneous ocular lesions facilitates accurate and consistent diagnosis and data interpretation.
Assuntos
Grupos Controle , Olho/patologia , Lentes Intraoculares/efeitos adversos , Administração Oftálmica , Animais , Córnea/efeitos dos fármacos , Córnea/patologia , Avaliação Pré-Clínica de Medicamentos , Olho/efeitos dos fármacos , Pálpebras/efeitos dos fármacos , Pálpebras/patologia , Feminino , Masculino , Preparações Farmacêuticas/administração & dosagem , Coelhos , Retina/efeitos dos fármacos , Retina/patologia , Estudos RetrospectivosRESUMO
OBJECTIVE: This study investigates the hypoperfusion effects of epinephrine in local anesthesia in eyelid surgery. A novel form of extended-wavelength diffuse reflectance spectroscopy was evaluated. METHODS: Blood perfusion in porcine eyelid flaps was measured using laser Doppler velocimetry and laser speckle contrast imaging, whereas the tissue response was measured using diffuse reflectance spectroscopy with a broad spectrum (450-1550 nm). Epinephrine was either injected cumulatively, 0.1 (1:10,000,000), 1.0 (1:1,000,000), 10 (1:100 000), and 100 µg/ml (1:10 000), to determine the dose-response relation, or given as a single dose (10 µg/ml). Control experiments were performed with saline or lidocaine. RESULTS: Increasing concentrations of epinephrine resulted in a gradual decrease in tissue perfusion, measured by laser Doppler velocimetry and laser speckle contrast imaging, approaching a minimum after the injection of 10 µg/ml. Similar tissue response was observed with diffuse reflectance spectroscopy. The time from the injection of epinephrine (10 µg/ml) to the stabilization of hypoperfusion was 75 seconds. After administration of 10 µg/ml epinephrine, about 20% of the blood perfusion remained, supporting the use of epinephrine in eyelid flaps with a narrow pedicle. CONCLUSIONS: 10 µg/ml epinephrine appears to be adequate for vasoconstriction before oculoplastic surgery. Incisions need only be delayed for about 1 minute. Extended-wavelength diffuse reflectance spectroscopy appears to be a promising technique for monitoring the tissue response following changes in blood perfusion in plastic surgery reconstructions. However, more rigorous validation of the technique is required before it can be implemented in clinical practice.
Assuntos
Anestesia Local/métodos , Anestésicos Locais/farmacologia , Epinefrina/farmacologia , Pálpebras , Vasoconstritores/farmacologia , Anestésicos Locais/administração & dosagem , Animais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Epinefrina/administração & dosagem , Pálpebras/irrigação sanguínea , Pálpebras/efeitos dos fármacos , Fluxometria por Laser-Doppler , Fluxo Sanguíneo Regional/efeitos dos fármacos , Análise Espectral , Retalhos Cirúrgicos/irrigação sanguínea , Suínos , Vasoconstrição/efeitos dos fármacosRESUMO
OBJECTIVE: To evaluate the use of perforated punctal plugs with adjuvant application of mitomycin-C in the management of acquired external punctal stenosis grades 0 and 1. METHODS: This is a prospective interventional case series including 30 eyes of 30 patients with acquired external punctal stenosis of the lower punctum of grades 0 and 1 presenting with epiphora. They were examined to exclude other causes of lacrimation and epiphora: Slit-lamp assessment of the stenosed punctum and grading was done, probing was done to exclude associated canalicular stenosis, and syringing was done to exclude nasolacrimal duct obstruction. For all cases, dilatation was done, followed by application of mitomycin-C, and perforated punctal plugs were then inserted. Plugs were removed after 6 months, and anatomical and functional success were assessed and followed during and for 6 months after removal of the plugs. RESULTS: The study included 30 patients with acquired external punctal stenosis: 9 males (30%) and 21 females (70%) with a mean age of 62.83 ± 8.3 years. Punctal stenosis grade 0 (no punctum) occurred in 9 cases (30%), and grade 1 (the punctum is covered by a membrane) occurred in 21 cases (70%). Six months after removal of the plugs, epiphora improved in 93.3% of patients, and fluorescein dye disappearance test results improved in 90% of patients; 6.7% of cases had early extrusion of the plug, and 3.3% had granuloma formation. CONCLUSIONS: Application of perforated punctal plugs combined with mitomycin-C is a simple and efficient technique in the management of tight acquired external punctal stenosis.
Assuntos
Alquilantes/administração & dosagem , Pálpebras/patologia , Aparelho Lacrimal/patologia , Obstrução dos Ductos Lacrimais/terapia , Mitomicina/administração & dosagem , Plug Lacrimal , Adulto , Idoso , Idoso de 80 Anos ou mais , Terapia Combinada , Desenho de Equipamento , Pálpebras/efeitos dos fármacos , Feminino , Corantes Fluorescentes/administração & dosagem , Humanos , Obstrução dos Ductos Lacrimais/classificação , Obstrução dos Ductos Lacrimais/patologia , Masculino , Pessoa de Meia-Idade , Estudos ProspectivosRESUMO
PURPOSE: The purpose of this study is to describe a new complication of a xanthelasma-like reaction which appeared after dermal filler injection in the lower eyelid region. METHODS: A retrospective case analysis was performed on 7 patients presenting with xanthelasma-like reaction after filler injection to the lower eyelids. RESULTS: Seven female subjects with no history of xanthelasma presented with xanthelasma-like reaction in the lower eyelids post filler injection. Fillers included hyaluronic acid (2 patients), synthetic calcium hydroxyapatite (4 patients), and polycaprolactone microspheres (one patient). Average time interval between filler injection and development of xanthelasma-like reaction was 12 months (range: 6-18 months). Treatment included steroid injections, 5FU injections, ablative or fractionated CO2 laser, and direct excision. Pathology confirmed the lesion was a true xanthelasma in one patient. In treated patients, there was subtotal resolution after laser. Xanthelasma-like reaction resolved completely after direct excision. Three patients elected to have no treatment. CONCLUSIONS: Previously there has been one reported case of xanthelasma after filler injection. This case series is the largest to date. Furthermore, this series is notable because xanthelasma-like reactions appeared after injection with 3 different types of fillers. None of the patients had evidence of xanthelasma prefiller injection. The precise mechanism by which filler injection can lead to the formation of xanthelasma-like reaction is unclear. A possible mechanism may be related to binding of low-density lipoprotein and internalization by macrophages. Further investigation is required. Nevertheless, physicians performing filler injections should be aware of this new complication and treatment options.
Assuntos
Blefaroplastia/efeitos adversos , Doenças Palpebrais/induzido quimicamente , Pálpebras/patologia , Ácido Hialurônico/efeitos adversos , Xantomatose/induzido quimicamente , Adulto , Biópsia , Doenças Palpebrais/diagnóstico , Pálpebras/efeitos dos fármacos , Feminino , Seguimentos , Humanos , Ácido Hialurônico/administração & dosagem , Injeções , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Viscossuplementos/administração & dosagem , Viscossuplementos/efeitos adversos , Xantomatose/diagnósticoRESUMO
AIM: The aim of this study was to investigate whether infiltration of the upper eyelid skin is less painful with prilocaine than with lidocaine. METHODS: In 40 consecutive patients scheduled for bilateral upper blepharoplasty, one upper eyelid was anaesthetised with lidocaine with epinephrine and the other with prilocaine with felypressin. After injection of each upper eyelid, the patient scored the pain experienced on infiltration using a visual analogue scale (0-10). In addition, the surgeon scored the need for reinjection during the operation; differences in perioperative bleeding; and degree of oedema, erythema and haematoma before discharge on a four-point rating scale (no, minimal, moderate or severe). RESULTS: Pain scores were significantly lower in upper eyelids injected with lidocaine than in those injected with prilocaine (p = 0.036). In addition, scores for oedema, erythema and haematoma were significantly lower in upper eyelids anaesthetised with lidocaine than in those anaesthetised with prilocaine (respectively, p = 0.001, p = 0.004 and p = 0.000). CONCLUSIONS: Compared with prilocaine with felypressin, lidocaine with epinephrine is significantly less painful in anaesthetising the upper eyelids; gives significantly less postoperative oedema, erythema and haematoma; and provides better haemostasis during upper blepharoplasty. LEVEL OF EVIDENCE: This was a level II, randomised double-blinded crossover study.
Assuntos
Anestesia Local/métodos , Blefaroplastia/métodos , Pálpebras/efeitos dos fármacos , Lidocaína/administração & dosagem , Dor Pós-Operatória/diagnóstico , Prilocaína/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Blefaroplastia/efeitos adversos , Estudos Cross-Over , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Medição da Dor , Projetos Piloto , Medição de Risco , Resultado do TratamentoRESUMO
Purpose: To quantify and compare the effects of instillation with 10% phenylephrine and digital lifting on the contralateral upper eyelid of patients with involutional bilateral blepharoptosis. Methods: The present prospective clinical study involved patients with involutional bilateral blepharoptosis who underwent two tests: 1) digital lifting of the more ptotic eyelid and observation of the effect on the contralateral eyelid and 2) instillation of two drops of 10% phenylephrine in the more ptotic eye and observation of the effect on the contralateral eyelid. Patients were filmed before and 5, 10, and 15 min after instillation, and the resulting images were analyzed to obtain eyelid measurements. The results were tested using a linear mixed-effects model. Results: A total of 27 patients, ranging from 52 to 82 years of age (mean age 68.51 ± 8.21 years), 24 (88.88%) of whom were women, were included in the present study. In eyes that received instillation, the marginal distance reflex-1 (MDR1) values increased from baseline (1.21 ± 0.60 mm) until 10 min after instillation, then remained statistically unchanged until 15 min after instillation (2.42 ± 0.90 mm). Significant differences were observed in the contralateral eye of the group that underwent digital lifting (1.51 ± 0.53 mm - 1.63 ± 0.56 mm) and in the contralateral eye of the group that underwent 10% phenylephrine instillation (1.38 ± 0.54 mm - 1.63 ± 0.56 mm); p=0.02 and p<0.01, respectively. Conclusion: In all eyes, 10% phenylephrine elevated the upper eyelid, with improved eyelid height at 10 min after instillation. Significant differences were observed in the height of the contralateral eyelid when compared before and after each intervention in each group; however, this difference was very small and nearly undetectable by conventional clinical evaluation in the digital lifting group. However, the 10% phenylephrine eye-drop test resulted in substantial changes in MDR1 values ...
Objetivo: Quantificar e comparar o efeito da instilação do colírio de fenilefrina 10% com o levantamento manual da pálpebra superior contralateral de pacientes com ptose palpebral bilateral involucional. Métodos: Estudo clínico e prospectivo de pacientes com ptose palpebral bilateral involucional submetidos a dois testes: 1) elevação manual da pálpebra mais ptótica e observação do efeito da intervenção na pálpebra contralateral; e 2) a instilação de duas gotas de colírio de fenilefrina 10% no olho mais ptótico e observação do efeito da intervenção na pálpebra contralateral. Os pacientes foram filmados antes e 5, 10 e 15 minutos após a instilação. Os resultados foram analisados estatisticamente com o modelo linear de efeitos mistos. Resultados: O estudo incluiu 27 pacientes com idade entre 52-82 anos (68,51 ± 8,21), 24 dos quais eram do sexo feminino (88,88%). Em olhos submetidos a instilação do colírio, os valores da DMR1 (distância marginal reflexo) aumentaram da linha de base (1,21 ± 0,60 mm) até os 10 min, em seguida, manteve-se estatisticamente estável até 15 min (2,42 ± 0,90 mm). Diferenças significativas foram observadas nos olhos contralaterais, independentemente do levantamento manual da pálpebra (1,51 ± 0,53 mm - 1,63 ± 0,56 milímetros) e da instilação do colírio de fenilefrina 10% (1,38 ± 0,54 mm - 1,63 ± 0,56 mm), p=0,02 e p<0,01 respectivamente. Conclusões: Em todos os olhos, a instilação do colírio de fenilefrina 10% mostrou um aumento gradual do valor de distância marginal reflexo até os 10 min. Nos olhos contralaterais houve diminuição do valor de distância marginal reflexo, independentemente do teste realizado, porém as mudanças que ocorrem na posição da pálpebra contralateral, durante o teste da elevação manual, são muito pequenas e difíceis de serem detectadas no exame clínico convencional. Enquanto isso, o teste de colírio de fenilefrina 10% produziu mudanças substanciais nos valores distância marginal reflexo nos ...
Assuntos
Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Agonistas de Receptores Adrenérgicos alfa 1/administração & dosagem , Blefaroptose/terapia , Pálpebras/efeitos dos fármacos , Fenilefrina/administração & dosagem , Blefaroptose/patologia , Pálpebras/patologia , Instilação de Medicamentos , Soluções Oftálmicas/administração & dosagem , Estudos Prospectivos , Valores de Referência , Procedimentos de Cirurgia Plástica/métodos , Fatores de Tempo , Resultado do TratamentoRESUMO
An allergic reaction was occurred in a 17-years old girl who was undergoing local anesthesia before tonsillectomy. Ptosis was observed in right side of patient shortly after injection of lidocaine to right palate. Then the patient feel grasp and cough, accompanied by nausea and vomiting. The patient was placed in supine position. Dexamethasone and epinephrine was administrated intramuscularly, symptoms were relieved 10 minutes later.
Assuntos
Lidocaína/efeitos adversos , Debilidade Muscular/induzido quimicamente , Adolescente , Anestesia Local/efeitos adversos , Pálpebras/efeitos dos fármacos , Feminino , HumanosRESUMO
PURPOSE: To evaluate the effect of local anesthesia with bupivacaine plus epinephrine on the extent of blepharoptosis and levator palpebrae muscle function. METHODS: : In this prospective interventional case series, patients with blepharoptosis who were candidates for aponeurotic surgery were included. After initial preparations in the operating room, a total of 1 ml of a mixture of bupivacaine 0.5% plus epinephrine 1:100,000 were injected into the upper eyelid. The margin reflex distance 1 (MRD1) and the extent of levator muscle function were measured before and 2, 5, 10, and 15 minutes after injection. RESULTS: A total of 36 eyes including 21 men (58.3%) and 15 women (41.7%) with an average age of 41.81 ± 23.09 (17-83 years) were studied. There were 21 eyes with myogenic and 15 eyes with aponeurotic blepharoptosis. The mean MRD1 was 1.18 ± 1.06 mm before injection and -0.02 ± 0.85, 0.52 ± 0.98, 0.98 ± 1.05, and 1.02 ± 1.06 mm at 2, 5, 10, and 15 minutes after injections, respectively. The changes in the MRD1 measurements were statistically significant at all time points. The MRD1 values decreased during the first 2 minutes after injection in 88.8% of eyes, but returned to initial value after 15 minutes in 84.3%. The change in the levator muscle function measurements was statistically significant at 2 and 5 minutes after injections; however, the differences were clinically negligible. CONCLUSIONS: : The local anesthesia of the eyelid with 1 ml bupivacaine plus epinephrine causes a temporary increase of blepharoptosis within the first few minutes with minimal effect on levator muscle function measurements.
Assuntos
Anestesia Local/métodos , Anestésicos Locais/administração & dosagem , Blefaroptose/fisiopatologia , Bupivacaína/administração & dosagem , Epinefrina/administração & dosagem , Músculos Oculomotores/fisiopatologia , Simpatomiméticos/administração & dosagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Blefaroptose/diagnóstico , Blefaroptose/cirurgia , Piscadela/fisiologia , Combinação de Medicamentos , Pálpebras/efeitos dos fármacos , Feminino , Humanos , Injeções Intraoculares , Masculino , Pessoa de Meia-Idade , Músculos Oculomotores/cirurgia , Estudos Prospectivos , Adulto JovemRESUMO
PURPOSE: To examine with histology the anatomical location of hyaluronic acid gel injected to the infraorbital hollows of cadaver specimens. METHODS: The authors dissected 5 fresh hemifacial cadaver specimens following preperiosteal injection of hyaluronic acid gel to the infraorbital hollows. Following tissue fixation, full-thickness soft tissue sections were obtained along the medial, central, and lateral lower eyelid/midface of each specimen. Histologic examination of the anatomical location of hyaluronic acid gel was performed using hematoxylin and eosin and Hale colloidal iron stains. RESULTS: Histologic examination of the central and lateral lower eyelid/midface sections revealed a significant portion of hyaluronic acid gel in either a postorbicularis or a subcutaneous plane in 8 of 10 sections. Only 2 sections displayed hyaluronic acid gel solely within a preperiosteal plane. The medial sections revealed hyaluronic acid gel resting in either a preperiosteal or an intraorbicularis plane. Soft tissue structures such as deep fat compartment septa and the orbicularis oculi muscle appeared to play a significant role in influencing the resting position of hyaluronic acid gel. CONCLUSIONS: In most specimens, the location of a significant portion of hyaluronic acid gel following injection to the infraorbital hollows differed from the intended injection plane. Soft tissue structures including fat compartment septa and the orbicularis oculi muscle appear to influence the resting position of hyaluronic acid gel. Careful attention should be used to avoid overfilling the thin soft tissue layers of the medial infraorbital hollows or tear trough.
Assuntos
Técnicas Cosméticas , Pálpebras/efeitos dos fármacos , Ácido Hialurônico/administração & dosagem , Órbita/efeitos dos fármacos , Viscossuplementos/administração & dosagem , Materiais Biocompatíveis/administração & dosagem , Cadáver , Pálpebras/patologia , Músculos Faciais/efeitos dos fármacos , Músculos Faciais/patologia , Humanos , Injeções Intradérmicas , Músculos Oculomotores/efeitos dos fármacos , Músculos Oculomotores/patologia , Órbita/patologia , Ritidoplastia , Envelhecimento da PeleRESUMO
A complex of measures for lid hygiene in ocular surface disease is developed. These measures together with tear substitution and antibacterial treatment were revealed to result in elimination of blepharoconjunctivitis and dry eye signs, recovery of tear film and long-time remission, that significantly improved patient's life quality. When using this complex of measures meibomian glands are not damaged and their anatomy and functions are completely preserved. Lid hygiene affects all glands, there is no pain and no local anesthesia needed, normal tear film is formed
Assuntos
Blefarite , Conjuntivite , Síndromes do Olho Seco , Ácido Hialurônico/uso terapêutico , Soluções Oftálmicas/uso terapêutico , Irrigação Terapêutica/métodos , Adulto , Blefarite/complicações , Blefarite/fisiopatologia , Conjuntivite/complicações , Conjuntivite/fisiopatologia , Síndromes do Olho Seco/complicações , Síndromes do Olho Seco/tratamento farmacológico , Síndromes do Olho Seco/fisiopatologia , Síndromes do Olho Seco/psicologia , Pálpebras/efeitos dos fármacos , Pálpebras/fisiopatologia , Feminino , Humanos , Higiene/normas , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Educação de Pacientes como Assunto/métodos , Lágrimas/metabolismo , Resultado do TratamentoRESUMO
BACKGROUND: Volume loss and muscular hyperactivity are two major components of the aging process that contribute to the formation of the folds and wrinkles. Tear trough deformity is one of the most difficult depressions to correct surgically. PURPOSE: The aim of this study was to evaluate the results of ten patients submitted to periorbital filling with hyaluronic acid gel filler. METHODS: Between June and August, 2008, 10 patients have had their tears troughs treated with hyaluronic acid gel filler. The filler was introduced by a serial puncture technique and approximately 0.1 ml was injected at each pass. The filler was placed in the pre-periosteal tissue. Patients photographs before and after the procedure were reviewed to assess the outcomes. RESULTS: The mean volume per side needed to achieve correction was on the right side 0.61 ml (SD=0.25) and on the left side 0.65 ml (SD=0.26). The most common complications were bruising, erythema, local swelling, and pain at the injection site. The effect of treatment lasted up to 12 months. CONCLUSIONS: This pilot study showed that the treatment of tear trough deformity with hyaluronic acid gel filler was feasible, predictable and effective. All patients were very satisfied with their results.
Assuntos
Pálpebras/efeitos dos fármacos , Ácido Hialurônico/administração & dosagem , Mesoterapia/métodos , Rejuvenescimento , Adulto , Técnicas Cosméticas/efeitos adversos , Feminino , Seguimentos , Humanos , Ácido Hialurônico/efeitos adversos , Injeções Subcutâneas , Mesoterapia/efeitos adversos , Pessoa de Meia-Idade , Satisfação do Paciente , Projetos Piloto , Estudos Prospectivos , Resultado do TratamentoRESUMO
OBJETIVO: Verificar a eficácia do preenchimento dos sulcos nasojugal e palpebromalar deprimidos através da injeção de ácido hialurônico e analisar as complicações observadas. MÉTODOS: Foi realizado um estudo piloto, prospectivo, aprovado pelo Comitê de Ética em Pesquisa da Universidade Federal de São Paulo, com pacientes recrutados no Serviço de Plástica Ocular do Departamento de Oftalmologia da UNIFESP/EPM. Foram selecionados pacientes de ambos os sexos, com idade entre 25 e 60 anos, que apresentavam os sulcos nasojugal e/ou palpebromalar deprimidos, que não haviam sido submetidos à cirurgia na pálpebra inferior nem apresentavam histórico de trauma nesse local. O ácido hialurônico foi aplicado via transcutânea e depositado na região supraperiosteal em pequenos volumes. Todo paciente foi tratado pelo mesmo cirurgião (GAPV), tendo sido examinado no pós-operatório em intervalos regulares e fotografado no pré-operatório, no pós-operatório imediato, na 4ª semana, no 6º e no 12º mês após o procedimento. Ao final deste período todas as fotos foram analisadas por profissional não ligado a esta pesquisa, visando verificar a eficiência da técnica em atingir seus objetivos. RESULTADOS: Entre junho e agosto de 2008, 10 pacientes foram incluídos neste estudo piloto. Oito pacientes foram tratadas uma única vez, enquanto duas precisaram de retoque na 4ª semana após a aplicação inicial. O volume injetado foi em média de 0,61 ml (DP=0,25) no lado direito e de 0,65 ml (DP=0,26) no lado esquerdo. As complicações observadas foram equimose em 6 casos, edema local maior que 48 horas em um paciente e lesão cutânea semelhante à acne em um participante. CONCLUSÕES: O estudo piloto demonstrou que o tratamento dos sulcos nasojugal e pálpebro-malar com uso de ácido hialurônico se mostrou eficaz e previsível, com alto nível de satisfação dos pacientes e com resultado duradouro.
BACKGROUND: Volume loss and muscular hyperactivity are two major components of the aging process that contribute to the formation of the folds and wrinkles. Tear trough deformity is one of the most difficult depressions to correct surgically. PURPOSE: The aim of this study was to evaluate the results of ten patients submitted to periorbital filling with hyaluronic acid gel filler. METHODS: Between June and August, 2008, 10 patients have had their tears troughs treated with hyaluronic acid gel filler. The filler was introduced by a serial puncture technique and approximately 0.1 ml was injected at each pass. The filler was placed in the pre-periosteal tissue. Patients photographs before and after the procedure were reviewed to assess the outcomes. RESULTS: The mean volume per side needed to achieve correction was on the right side 0.61 ml (SD=0.25) and on the left side 0.65 ml (SD=0.26). The most common complications were bruising, erythema, local swelling, and pain at the injection site. The effect of treatment lasted up to 12 months. CONCLUSIONS: This pilot study showed that the treatment of tear trough deformity with hyaluronic acid gel filler was feasible, predictable and effective. All patients were very satisfied with their results.
Assuntos
Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Pálpebras/efeitos dos fármacos , Ácido Hialurônico/administração & dosagem , Mesoterapia/métodos , Rejuvenescimento , Técnicas Cosméticas/efeitos adversos , Seguimentos , Ácido Hialurônico/efeitos adversos , Injeções Subcutâneas , Mesoterapia/efeitos adversos , Satisfação do Paciente , Projetos Piloto , Estudos Prospectivos , Resultado do TratamentoAssuntos
Blefaroplastia/efeitos adversos , Desinfetantes/toxicidade , Pálpebras/efeitos dos fármacos , Pálpebras/patologia , Formaldeído/toxicidade , Erros Médicos , Complicações Pós-Operatórias/induzido quimicamente , Pele/efeitos dos fármacos , Pele/patologia , Anestesia Local/efeitos adversos , Desinfetantes/administração & dosagem , Formaldeído/administração & dosagem , Humanos , Injeções Subcutâneas/efeitos adversos , Necrose , Complicações Pós-Operatórias/cirurgia , Recidiva , ReoperaçãoRESUMO
BACKGROUND: Evidence suggests that periorbital hyperchromia (dark circles) occurs mainly as a consequence of postinflammatory hemodynamic congestion producing a typical bruising aspect on the lower eyelids. AIMS: To evaluate the clinical effects of Pfaffia paniculata/Ptychopetalum olacoides B./Lilium candidum L.-associated compound (PPLAC) on periorbital hyperchromia and to study in vitro its underlying anti-inflammatory and antioxidant mechanisms. METHODS: Twenty-one volunteers presenting with periorbital hyperchromia received a serum sample containing 5.0% PPLAC, which was applied topically in the periorbital area twice a day for 28 days. Skin color was measured using variations in the individual typological angle (DeltaITA(0)) and skin luminance (DeltaL*) calculated in the area around the eyes and in the adjacent area. Colorimetric readings were taken at the onset and end of the 28-day treatment. Volunteers were also asked to fill out a questionnaire concerning the improvement in "dark circles." The anti-inflammatory and antioxidant effects of PPLAC were measured by quantification of prostaglandin E(2), leukotriene B(4), histamine, and superoxide dismutase levels using an in vitro model of human skin culture. RESULTS: Topical application of PPLAC led to a significant improvement in skin luminance and tone in the periorbital area, which was demonstrated by increased values of ITA(0) and L* in about 90% of volunteers. In addition, subjects reported reduced intensity and improved appearance of "dark circles." A dose-dependent decreased production of inflammatory mediators, concomitant to increased antioxidant enzyme levels, was observed in our in vitro studies, under basal and lipopolysaccharide-stimulated conditions. CONCLUSIONS: Although the precise mechanisms related to PPLAC remain to be clarified, our results indicate that the reduction in the inflammatory process as well as the antioxidant protection against deleterious elements may be considered as an integral approach to preserve the integrity of vascular endothelium, preventing the hemodynamic congestion that culminates in the formation of "dark circles" around the eyes.
Assuntos
Amaranthaceae , Antioxidantes/uso terapêutico , Pálpebras/efeitos dos fármacos , Hiperpigmentação/tratamento farmacológico , Lilium , Olacaceae , Fitoterapia/métodos , Extratos Vegetais/uso terapêutico , Administração Cutânea , Adulto , Antioxidantes/administração & dosagem , Antioxidantes/farmacologia , Brasil , Emolientes , Pálpebras/patologia , Feminino , Humanos , Hiperpigmentação/patologia , Técnicas In Vitro , Pessoa de Meia-Idade , Órbita , Satisfação do Paciente , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Rejuvenescimento , Envelhecimento da Pele/efeitos dos fármacos , Inquéritos e Questionários , Resultado do TratamentoRESUMO
PURPOSE: To determine whether a regimen of topical moxifloxacin hydrochloride ophthalmic solution 0.5% (Vigamox) administered on the day of cataract surgery reduces conjunctival bacterial flora. SETTING: Iladevi Cataract & IOL Research Centre, Ahmedabad, India. METHODS: Seventy-four patients were prospectively randomized to receive Vigamox 4 times 1 day before surgery plus 1 drop 2 hours preoperatively (Group 1) and 74 patients, to receive Vigamox 2 hours before surgery and every 15 minutes in the first hour only (Group 2). Conjunctival swabs from the upper and lower lid margins and lower fornix were taken before and after Vigamox instillation. Aliquots were spread on chocolate blood, anaerobic basal, and nutrient agars. The number of bacterial colony-forming units (CFU) on the plates was counted with a grid technique and expressed as log values. The total number of CFU per eye and mean percentage reduction in CFU after instillation were calculated. Bacterial species were identified using biochemical and biophysical reactions. Wilcoxon signed ranked and Mann-Whitney tests and multiple linear regression were applied. RESULTS: In Group 1, the median colony count decreased from 1284.00 CFU +/- 643.18 (SD) before Vigamox instillation to 65.00 +/- 72.61 CFU after instillation (93.12% reduction) (P<.001) and in Group 2, from 1634.00 +/- 769.27 CFU to 75.00 +/- 81.23 CFU (93.28% reduction) (P<.001). The percentage reduction after instillation was similar between the 2 groups (P = .09). CONCLUSION: Both Vigamox regimens reduced the number of CFU of conjunctival flora, indicating that instillation beginning on the day of surgery is effective.
Assuntos
Anti-Infecciosos/uso terapêutico , Antibioticoprofilaxia , Compostos Aza/uso terapêutico , Túnica Conjuntiva/efeitos dos fármacos , Túnica Conjuntiva/microbiologia , Soluções Oftálmicas/uso terapêutico , Quinolinas/uso terapêutico , Administração Tópica , Idoso , Idoso de 80 Anos ou mais , Bactérias/efeitos dos fármacos , Bactérias/isolamento & purificação , Extração de Catarata , Contagem de Colônia Microbiana , Métodos Epidemiológicos , Pálpebras/efeitos dos fármacos , Pálpebras/microbiologia , Feminino , Fluoroquinolonas , Humanos , Masculino , Pessoa de Meia-Idade , Moxifloxacina , Estudos ProspectivosRESUMO
BACKGROUND: Though a needleless jet injection device (NJI device) has advantages over a conventional needle attached syringe for injecting anesthetics, safety of using it for lid surgery is not proved. We report a case of posterior segment injury suspected caused by a NJI device. METHODS: A 47-year-old woman presented with decreased visual acuity after regional anesthesia at the lower eyelids with a NJI device. RESULTS: Vitreous and subretinal hemorrhage was found associated with retinal edema adjacent to the optic disc of the right eye and around the inferior temporal arcade of the left eye. Fluorescein angiography revealed choroidal rupture in the both eyes. By 2 months, although the hemorrhage resolved, subretinal fibrosis and chorioretinal atrophy developed. Her vision decreased to 20/60 in the right eye and 20/40 in the left eye. CONCLUSION: The energy generated by the NJI device seemed to have reached the eyeballs to cause the blunt-typed posterior segment injuries. As choroidal rupture may result in a permanent visual loss, the risks associated the off-labeled use of the device for lid surgeries should be awakened.